Zheng Quan Shi Bao·2025-08-02 08:44Market Activity - In July, the Shanghai Composite Index increased by 3.74%, marking the highest level for the same period in nearly five years [1] - The average turnover rate and average daily trading volume in the A-share market reached 3.84% and 1.63 trillion yuan, respectively, both hitting new highs since March [1] - Net purchases by margin traders in July amounted to nearly 132.9 billion yuan, the highest monthly figure this year, with three consecutive months of net buying [1] - Northbound trading volume reached 444.5 billion yuan, 1.5 times that of June, setting a new monthly record for the year [1] Institutional Ratings - In July, 60 institutions conducted a total of 1,482 "buy" ratings, covering 720 stocks across 31 industries, with 10 industries having 20 or more stocks rated [3] - The electronics sector had the highest number of stocks rated, totaling 99, with a 6.59% increase in the Shenwan Electronics Index in July [5] - The pharmaceutical and biotechnology sector followed with over 70 stocks, experiencing a nearly 14% increase in the Shenwan Pharmaceutical Index in July [6] Key Stocks - Among the 720 stocks, 64 received five or more "buy" ratings in July, with 11 stocks receiving at least 10 ratings [7] - Dongpeng Beverage received the highest number of "buy" ratings at 34, with analysts noting its diversified product matrix and potential for growth in Southeast Asia [7][9] - WuXi AppTec received 18 "buy" ratings, ranking second, while Ecovacs Robotics received 14 [8][9] Performance of Recommended Stocks - As of August 1, 103 stocks were recommended as "golden stocks" for August, with Dongpeng Beverage and Huadian Electric among those that underperformed the Shanghai Composite Index since July [10] - Dongpeng Beverage's stock price fell over 9% since July, despite a 37.22% year-on-year increase in net profit for the first half of 2025 [11][13] - Jiangfeng Electronics and Perfect World also saw stock price declines of nearly 7% and over 3%, respectively, despite significant projected profit growth [11][13]